MarketBeat
25 Sept 2026, 00:02 UTC · 2h ago
Verdict
Headline takes no side. We score CMPS +0.80 across five claims — strongly bullish.
+0.80strongly bullish
More positive than 87% of ticker scores this week
What the story claims
5 claims · scored −1 bearish … +1 bullish · 4 new · 1 priced in
Compass Pathways is on track to complete its rolling NDA submission for COMP360 in Q4.
NewCEO spoke at TD Cowen Summit on Sept 25
So whatCompletion of the filing triggers a potential 60-day FDA acceptance window before the review clock starts.
More positive than 93% of claims this week
Phase III extension data shows durability of response through 52 weeks with up to three treatments.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
NewCPO discussed top-line results at TD Cowen Summit
More positive than 86% of claims this week
The company expects the DEA rescheduling process to typically take about 90 days following FDA approval.
Priced indiscussion of typical DEA process
So whatThis creates a 3-month revenue lag between FDA approval and actual commercial launch in 2027.
More positive than 64% of claims this week
Compass expects CPT codes to remain Category III at launch, with conversion to Category I potentially taking 18 months.
NewCEO/CCO comments at TD Cowen Summit
So whatLower initial reimbursement rates for providers may slow the adoption rate at interventional centers during H1 2027.
More positive than 52% of claims this week
Initial commercial focus will target the top 2,000 interventional psychiatry centers that drive 80% of Spravato volume.
NewCCO comments at TD Cowen Summit
More positive than 43% of claims this week
Which stocks this story touches
More positive than 87% of ticker scores this week
The company is on track for its NDA submission with strong Phase III extension data and a clear commercial launch strategy.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Seeking Alpha
6h ago
—
CMPS hasn't traded since this ran. Last close $13.09 (Sep 24); the reaction starts at the next open.
CMPS chart →
